These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7603262)

  • 1. Are focal white matter lesions in patients with inflammatory bowel disease linked to multiple sclerosis?
    Agranoff D; Schon F
    Lancet; 1995 Jul; 346(8968):190-1. PubMed ID: 7603262
    [No Abstract]   [Full Text] [Related]  

  • 2. Focal white-matter lesions in brain of patients with inflammatory bowel disease.
    Geissler A; Andus T; Roth M; Kullmann F; Caesar I; Held P; Gross V; Feuerbach S; Schölmerich J
    Lancet; 1995 Apr; 345(8954):897-8. PubMed ID: 7707814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortical lesions and brain atrophy in MS.
    Kutzelnigg A; Lassmann H
    J Neurol Sci; 2005 Jun; 233(1-2):55-9. PubMed ID: 15893328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crohn's disease in a patient with multiple sclerosis.
    Kitchin LI; Knobler RL; Friedman LS
    J Clin Gastroenterol; 1991 Jun; 13(3):331-4. PubMed ID: 2066551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypersexuality, fetishism and multiple sclerosis.
    Huws R; Shubsachs AP; Taylor PJ
    Br J Psychiatry; 1991 Feb; 158():280-1. PubMed ID: 2012924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain atrophy in multiple sclerosis: therapeutic, cognitive and clinical impact.
    Rojas JI; Patrucco L; Miguez J; Cristiano E
    Arq Neuropsiquiatr; 2016 Mar; 74(3):235-43. PubMed ID: 27050854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortical demyelination and diffuse white matter injury in multiple sclerosis.
    Kutzelnigg A; Lucchinetti CF; Stadelmann C; Brück W; Rauschka H; Bergmann M; Schmidbauer M; Parisi JE; Lassmann H
    Brain; 2005 Nov; 128(Pt 11):2705-12. PubMed ID: 16230320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cerebral atrophy in multiple sclerosis: a controlled study (author's transl)].
    Aschoff JC; Lischewski R; Magos J
    Nervenarzt; 1979 Oct; 50(10):638-42. PubMed ID: 537656
    [No Abstract]   [Full Text] [Related]  

  • 9. Crohn's disease and multiple sclerosis: a single case report.
    Buccino GP; Corrente G; Visintini D
    Ital J Neurol Sci; 1994 Sep; 15(6):303-6. PubMed ID: 7843946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathologic substrate of magnetic resonance alterations in multiple sclerosis.
    Lassmann H
    Neuroimaging Clin N Am; 2008 Nov; 18(4):563-76, ix. PubMed ID: 19068402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathology and disease mechanisms in different stages of multiple sclerosis.
    Lassmann H
    J Neurol Sci; 2013 Oct; 333(1-2):1-4. PubMed ID: 23735777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis.
    Singh S; Dallenga T; Winkler A; Roemer S; Maruschak B; Siebert H; Brück W; Stadelmann C
    J Neuroinflammation; 2017 Mar; 14(1):57. PubMed ID: 28302146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain white-matter lesions in inflammatory bowel disease.
    Hart PE; Gould SR; MacSweeney JE; Clifton A; Schon F
    Lancet; 1998 May; 351(9115):1558. PubMed ID: 10326545
    [No Abstract]   [Full Text] [Related]  

  • 14. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter.
    Vercellino M; Masera S; Lorenzatti M; Condello C; Merola A; Mattioda A; Tribolo A; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
    J Neuropathol Exp Neurol; 2009 May; 68(5):489-502. PubMed ID: 19525897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Differential diagnosis of the clinical picture of multiple sclerosis in MR tomography].
    Gowin W; Mariss G
    Digitale Bilddiagn; 1986 Sep; 6(3):111-7. PubMed ID: 3769396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gray matter damage in multiple sclerosis: Impact on clinical symptoms.
    van Munster CE; Jonkman LE; Weinstein HC; Uitdehaag BM; Geurts JJ
    Neuroscience; 2015 Sep; 303():446-61. PubMed ID: 26164500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortical deafness in multiple sclerosis.
    Tabira T; Tsuji S; Nagashima T; Nakajima T; Kuroiwa Y
    J Neurol Neurosurg Psychiatry; 1981 May; 44(5):433-6. PubMed ID: 7264691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White matter and lesion T1 relaxation times increase in parallel and correlate with disability in multiple sclerosis.
    Parry A; Clare S; Jenkinson M; Smith S; Palace J; Matthews PM
    J Neurol; 2002 Sep; 249(9):1279-86. PubMed ID: 12242554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway.
    Sepulcre J; Goñi J; Masdeu JC; Bejarano B; Vélez de Mendizábal N; Toledo JB; Villoslada P
    Arch Neurol; 2009 Feb; 66(2):173-9. PubMed ID: 19204153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural brain indices and executive functioning in multiple sclerosis: A review.
    Roman CA; Arnett PA
    J Clin Exp Neuropsychol; 2016; 38(3):261-74. PubMed ID: 26757595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.